Document is current
Any future updates will be listed below
-
Authors
Tsuchiya, Norihiko https://orcid.org/0000-0003-4242-2618
Naito, Sei
Fukuhara, Hiroki
Nishida, Hayato
Yagi, Mayu
Takai, Yuki
Yamagishi, Atsushi
Narisawa, Takafumi
Suenaga, Shinta
- License Information
-
More Information
Article History
Received: 17 June 2025
Accepted: 6 August 2025
First Online: 23 January 2026
Declarations
:
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: N.T. received honoraria from Pfizer Inc., Eisai Co. Ltd., Novartis Pharmaceuticals Co., Ono Pharmaceutical Co. Ltd., Merck & Co. Inc., MSD Japan, and Takeda Pharmaceutical Co. Ltd. S.N. received honoraria from Bristol Myers Squibb Co., Ono Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Eisai Co. Ltd., Merck & Co. Inc., Pfizer Inc., and MSD Japan. T.N. received honoraria from MSD Japan, and Bristol-Myers Squibb Co. H.F., H.N., M.Y., A.Y., Y.T., and S.S. have no conflict of interest.
: This study was approved by the institutional review board of the Faculty of Medicine at Yamagata University (2018-43).
